newsfilter
← Latest News
Business Wire·

Athersys to Participate in Three Upcoming Conferences

Athersys, Inc. (NASDAQ:ATHX), a regenerative medicine company developing MultiStem® (invimestrocel) cell therapy for critical care indications, announced today its participation in three upcoming conferences during